| Michelle Bitter-oakley, | |
|
9749 W Sample Rd, Coral Springs, FL 33065-4003 | |
| (954) 840-3035 | |
| Not Available |
| Full Name | Michelle Bitter-oakley |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 9749 W Sample Rd, Coral Springs, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114508959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Bitter-oakley, 9749 W Sample Rd, Coral Springs, FL 33065-4003 Ph: (954) 840-3035 | Michelle Bitter-oakley, 9749 W Sample Rd, Coral Springs, FL 33065-4003 Ph: (954) 840-3035 |
News Archive
Moderate exercise may help people cope with anxiety and stress for an extended period of time post-workout, according to a study by kinesiology researchers in the University of Maryland School of Public Health published in the journal Medicine and Science in Sports and Exercise.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
After receiving a priority review, Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved SPRYCEL (dasatinib) 100 mg once daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
The phase 3 AVERROES (Apixaban Versus Acetylsalicylic acid (ASA) to Prevent Strokes) trial, designed to show the superiority of apixaban over aspirin for the prevention of stroke or systemic embolism in high-risk atrial fibrillation patients unsuitable for treatment with a vitamin K antagonist (warfarin), was terminated early following a recommendation from the Data Monitoring Committee.
MingSight Pharmaceuticals announced today that it has acquired the exclusive worldwide rights from Pfizer to develop, manufacture, and commercialize two preclinical stage new chemical entities for the prevention and treatment of human diseases.
› Verified 6 days ago
Mrs. Cindy Ricardo Lanauze, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 9900 W Sample Rd, 209, Coral Springs, FL 33065 Phone: 954-793-6442 | |
Angel M Aguasvivas, MHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7501 Wiles Rd Ste 105, Coral Springs, FL 33067 Phone: 954-341-1022 | |
Mrs. Iren Royter, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4743 Nw 121st Ave Fl 33076, Coral Springs, FL 33076 Phone: 954-778-7884 | |
Mrs. Marsha Linda Gutsin, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10220 W Sample Rd, Coral Springs, FL 33065 Phone: 954-752-1330 Fax: 954-755-4233 | |
Melanie Mcmillion, Counselor Medicare: Medicare Enrolled Practice Location: 1515 N University Dr Ste 216, Coral Springs, FL 33071 Phone: 954-755-8247 Fax: 954-755-8255 | |
Dr. Jasset Smith, PSY.D., LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1881 N University Dr, Suite 104, Coral Springs, FL 33071 Phone: 954-340-0888 Fax: 954-346-0909 | |
Natalie Jacobs, RMHCI Counselor Medicare: Not Enrolled in Medicare Practice Location: 1837 Nw 85th Ln, Coral Springs, FL 33071 Phone: 239-281-9709 |